In-house roundup: How to manage AI applications; pharma unconcerned by NHS provision; fintech embraces open source

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: How to manage AI applications; pharma unconcerned by NHS provision; fintech embraces open source

Drugs

Managing IP rounds up the latest news and analysis from patent-focused businesses



Drugs

How financial services firms manage AI applications

Counsel at Equifax, Morgan Stanley and American Express say streamlining relationships with external counsel and disclosing data sets correctly are key to prosecuting artificial intelligence patents. Read more... 

Pharma companies unconcerned by NHS notification in preliminary injunctions

In-house sources say changes to the England and Wales Patents Court Guide setting out that health authorities must be notified in the case of an injunction for an approved therapeutic product are not a cause for concern. Read more... 

Digital transformation pushes firms to embrace open source

Microsoft, JPMorgan and Wells Fargo explain how the cloud, AI and data sets technologies are driving them to open source and how that change is affecting patent strategies. Read more... 





more from across site and SHARED ros bottom lb

More from across our site

Tilleke & Gibbins topped the leaderboard with four awards across the region, while Anand & Anand and Kim & Chang emerged as outstanding domestic firms
News of a new addition to Via LA’s Qi wireless charging patent pool, and potential fee increases at the UKIPO were also among the top talking points
The keenly awaited ruling should act as a ‘call to arms’ for a much-needed evolution of UK copyright law, says Rebecca Newman at Addleshaw Goddard
Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Frederick Lee has rejoined Boies Schiller Flexner, bolstering the firm’s capabilities across AI, media, and entertainment
Nirav Desai and Sasha S Rao at Sterne, Kessler, Goldstein & Fox explore how companies’ efforts to manage tariffs by altering corporate structures can undermine their ability to assert their patents and recover damages
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Lawyers say attention will turn to the UK government’s AI consultation after judgment fails to match pre-trial hype
Gift this article